A sequence to sequence learning based car-following model for multi-step predictions considering reaction delay

Lijing Ma,Shiru Qu
DOI: https://doi.org/10.1016/j.trc.2020.102785
2020-11-01
Abstract:<p>Car-following behavior modeling is of great importance for traffic simulation and analysis. Considering the multi-steps decision-making process in human driving, we propose a sequence to sequence (seq2seq) learning based car-following model incorporating not only memory effect but also reaction delay. Since the seq2seq architecture has the advantage of handling variable lengths of input and output sequences, in this paper, it is applied to car-following behavior modeling to memorize historical information and make multi-step predictions. We further compare the seq2seq model with a classical car-following model (IDM) and a deep learning car-following model (LSTM). The evaluation results indicate that the proposed model outperforms others for reproducing trajectory and capturing heterogeneous driving behaviors. Moreover, the platoon simulation demonstrates that the proposed model can well reproduce different levels of hysteresis phenomenon. The proposed model is further extended with spatial anticipation, which improves platoon simulation accuracy and traffic flow stability.</p>
What problem does this paper attempt to address?
The main problems that this paper attempts to solve are the detection and characterization of vulnerable coronary plaques. Specifically, the paper explores how to identify and evaluate these vulnerable plaques through angioscopy technology, and how to conduct more in - depth research using new imaging technologies such as chromo - angioscopy, near - infrared fluorescence angioscopy and color fluorescence angioscopy. In addition, the paper also discusses the application of drug - eluting stents (DES) in treatment and their potential problems, such as late stent thrombosis (LST), and proposes possible solutions. The following are the specific problems mentioned in the paper: 1. **Detection of vulnerable coronary plaques**: - Traditional angioscopy mainly relies on surface color and morphology to judge the nature of plaques. Research shows that dark - yellow or shiny - yellow plaques are considered vulnerable plaques. - In order to evaluate the color of plaques more accurately, a chromaticity measurement device has been developed for quantitative analysis. 2. **Limitations of traditional angioscopy**: - Since only the surface features of plaques can be observed, traditional angioscopy has limitations in detecting vulnerable plaques. Therefore, new imaging technologies need to be developed to overcome these limitations. 3. **Application of new imaging technologies**: - New technologies such as chromo - angioscopy, near - infrared fluorescence angioscopy and color fluorescence angioscopy are used for molecular imaging to more accurately characterize vulnerable coronary plaques. - Near - infrared fluorescence angioscopy has been successfully applied to patients and can perform two - dimensional imaging of cholesterol and cholesterol esters and distinguish different types of plaques. 4. **Problems and improvements of drug - eluting stents (DES)**: - DES significantly reduces the occurrence of coronary restenosis, but may lead to late stent thrombosis (LST), which requires long - term anti - platelet treatment. - Research shows that the neointimal coverage of DES is incomplete, increasing the risk of LST. Therefore, new stent designs need to be developed to solve these problems. 5. **Stability and regression assessment of vulnerable plaques**: - By evaluating the impact of lipid - lowering therapy on coronary plaques through angioscopy, it is found that the color grade of yellow plaques has decreased. - Different plaques respond differently to treatment, and further research is needed to optimize treatment methods. In summary, this paper aims to improve the detection and characterization ability of vulnerable coronary plaques through a variety of imaging technologies and methods, thereby providing more effective means for the prevention and treatment of cardiovascular diseases.